Malin Corporation plc
Research Malin Corporation plc (MLC) on Bullrun: market cap EUR 30.35M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerMLC
- ExchangeIR
- CountryIreland
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyEUR
- Market capEUR 30.35M
- Financial periodFY2024
- RevenueEUR 0
- Net incomeEUR 0
- Free cash flow-EUR 1.30M
Valuation Snapshot
latest market cap is EUR 30.35M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2024 | EUR 0 | EUR 0 | -EUR 1.30M | n/a | n/a | EUR 62.10M | EUR 0 | EUR 193.20M |
| FY2023 | EUR 0 | EUR 0 | -EUR 3.20M | n/a | 0 | EUR 29.30M | EUR 100.00K | EUR 109.50M |
| FY2022 | EUR 0 | EUR 12.90M | -EUR 7.20M | n/a | 0.38 | EUR 173.90M | EUR 100.00K | EUR 283.10M |
| FY2021 | EUR 0 | EUR 37.80M | -EUR 6.20M | n/a | 0.85 | EUR 32.70M | EUR 100.00K | EUR 218.90M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-23 | EUR 30.35M | n/a | n/a | n/a |
About Malin Corporation plc
Malin Corporation plc, together with its subsidiaries, operates as an investment company in Europe and North America. It engages in the investment in life sciences and healthcare companies targeting various therapeutic areas, including oncology, immunology, and genetic diseases. The company was incorporated in 2014 and is headquartered in Dublin, Ireland.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Malin Corporation plc's market cap?
Malin Corporation plc's market capitalization is EUR 30.35M.
What does Malin Corporation plc do?
Malin Corporation plc, together with its subsidiaries, operates as an investment company in Europe and North America. It engages in the investment in life sciences and healthcare companies targeting various therapeutic areas, including oncology, immunology, and genetic diseases. The company was incorporated in 2014 and is headquartered in Dublin, Ireland.